You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 297 No. 19, May 16, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (10)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Breast Cancer
 •Dermatology
 •Melanoma
 •Alert me on articles by topic

Genomic Instability Within Tumor Stroma and Clinicopathological Characteristics of Sporadic Primary Invasive Breast Carcinoma

Koichi Fukino, MD, PhD; Lei Shen, PhD; Attila Patocs, MD, PhD; George L. Mutter, MD; Charis Eng, MD, PhD

JAMA. 2007;297:2103-2111.

Context  That genomic alterations occur in both the epithelium and stroma of sporadic breast cancers has been documented by several groups. However, whether these microenvironmental alterations relate to clinicopathological features is unknown.

Objective  To analyze the relationship between stromal genomic alterations and presenting clinicopathological features in sporadic breast cancer.

Design, Setting, and Participants  A retrospective cross-sectional analysis of DNA from the epithelium and stroma of 220 primary sporadic invasive breast carcinomas for global genomic alterations manifested by loss of heterozygosity/allelic imbalance with 386 microsatellite markers. Data were collected from October 2003 through June 2006 from samples at Brigham and Women's Hospital, Boston, Mass.

Main Outcome Measures  Association of the loss of heterozygosity/allelic imbalance, in both the stroma and epithelium, with presenting clinicopathological features, such as tumor grade, expression status of estrogen receptor and progesterone receptor, human epidermal growth factor receptor 2, clinical stage, and regional lymph node metastasis status. Associations were assessed in regression models and tested with Fisher exact test. Bonferroni correction was applied to P values, with significance set at P<.0022.

Results  We found significant associations between loss of heterozygosity/allelic imbalance on chromosome 11 in the stroma and tumor grade (P = .0013), on chromosomes 1, 2, 5, 18, 20, and 22 in the stroma and regional lymph node metastasis (P = .0002-.0016), and on chromosome 14 in the epithelium and progesterone-receptor expression status (P = .002). Specific markers contributing to the loss of heterozygosity/allelic imbalance on chromosome 11 in the stroma associated with tumor grade were D11S1999 (P = .00055) and D11S1986 (P = .042). The loss of heterozygosity/allelic imbalance at various markers in the stroma was significantly associated with regional lymph node metastasis: ATA42G12 (chromosome 1, P = .00095), D5S1457 (P = .00095), D5S1501 (P = .0011), D5S816 (P = .0008), D18S858 (P = .0026), D20S103 (P = .0027), D20S851 (P = .0045), D22S683 (P = .00033), and D22S1045 (P = .0013).

Conclusions  There were more correlations between clinicopathological features and the loss of heterozygosity/allelic imbalance in the stroma than in the epithelium, suggesting that stromal genomic alterations may help account for clinical diversity. Future research is necessary to validate these results and investigate their significance for prognosis and outcome.


Author Affiliations: Genomic Medicine Institute, Lerner Research Institute and Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, Ohio (Drs Fukino, Shen, Patocs, and Eng); Department of Neurosurgery, Nippon Medical School, Tokyo, Japan (Dr Fukino); Division of Biostatistics, The Ohio State University School of Public Health, Columbus (Dr Shen); Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass (Dr Mutter); and Department of Genetics and CASE Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio (Dr Eng).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Breast Carcinoma-Associated Fibroblasts and Their Counterparts Display Neoplastic-Specific Changes
Hawsawi et al.
Cancer Res. 2008;68:2717-2725.
ABSTRACT | FULL TEXT  

Frequency of Germline Genomic Homozygosity Associated With Cancer Cases
Assie et al.
JAMA 2008;299:1437-1445.
ABSTRACT | FULL TEXT  

Equilibrium between Host and Cancer Caused by Effector T Cells Killing Tumor Stroma
Zhang et al.
Cancer Res. 2008;68:1563-1571.
ABSTRACT | FULL TEXT  

Somatic acquisition of TGFBR1*6A by epithelial and stromal cells during head and neck and colon cancer development
Bian et al.
Hum Mol Genet 2007;16:3128-3135.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.